The NAT10/ac4C axis in liver disease: an epitranscriptomic rheostat from steatosis to hepatocellular carcinoma
Аннотация
Publication date: December 2026 Source: Medicine Plus, Volume 3, Issue 4 Author(s): Yingli Zhu, Xiaolong Zhou
Publication date: December 2026 Source: Medicine Plus, Volume 3, Issue 4 Author(s): Yingli Zhu, Xiaolong Zhou
Advanced NanoBiomed Research, EarlyView.
Clinical and Translational Medicine, Volume 16, Issue 11, November 2026.
Clinical and Translational Medicine, Volume 16, Issue 11, November 2026.
Nature Biomedical Engineering, Published online: 18 November 2026; doi:10.1038/s41551-026-01843-z Tumour-associated mucins induce the disassembly of a designer PEGylated paclitaxel-conjugated nanomedicine into small unimers that escape...
MedComm – Biomaterials and Applications, Volume 5, Issue 4, December 2026.